Cite
HARVARD Citation
Lin, C. et al. (2021). The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis. Thoracic cancer. 12 (7), pp. 1084-1095. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lin, C. et al. (2021). The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis. Thoracic cancer. 12 (7), pp. 1084-1095. [Online].